Bide Pharmatech Co., Ltd.

Bide Pharmatech Co., Ltd. faced a notable stock decline, dropping significantly on March 23, 2026. The company's performance has lagged behind the broader market over various timeframes. However, it reported positive financial metrics, including increased net sales and reduced raw material costs, maintaining an appealing valuation profile.

Bide Pharmatech Co., Ltd. saw a notable increase in its stock today, reaching an intraday high. Despite recent declines over the past week and month, the company reported strong financial results, including record net sales and improved debtors turnover, highlighting its ongoing valuation strength in the market.